Recursion Pharmaceuticals 
RXRX is looking at a strong bullish bottoming out after the stock saw strong break out of the falling wedge and the breaking out of the small range at the 2nd bottom of the larger double bottom. Volume surge and reiterate the buying pressure.
Mid-term stochastic oscillator is showing oversold crossover and 23-period roc is rising and is clearing above the zero line. Meanwhile, IChimoku's 9-period conversion and 26-period base line is showing early signs of bullish crossover
RXRX is looking at a strong bullish bottoming out after the stock saw strong break out of the falling wedge and the breaking out of the small range at the 2nd bottom of the larger double bottom. Volume surge and reiterate the buying pressure. Mid-term stochastic oscillator is showing oversold crossover and 23-period roc is rising and is clearing above the zero line. Meanwhile, IChimoku's 9-period conversion and 26-period base line is showing early signs of bullish crossover
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。